HSV thymidine kinase inhibitors (GLSynthesis)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameHSV thymidine kinase inhibitors (GLSynthesis)
Drug Alias NameGLS-122E prodrugs (GLSynthesis)SacrovirGLS-122EGLS-361B
ClassificationSmall molecules
Mechanisms of ActionThymidine kinase inhibitorsHSV replication inhibitors
TargetsThymidine kinase
Therapy Area/IndicationsHerpes Simplex
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlsynthesis Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlsynthesis Inc
Active IndicationsN/A
Inactive IndicationsHerpes Simplex

Other Information

ATC CodeN/A
Related LinksN/A